
The Pancreatic Cancer Drug That Just DOUBLED Survival Odds
An experimental new pill, daraxonrasib, significantly improved survival rates of participants with pancreatic cancer. Israel Sebastian/Getty Images A new medication performed remarkably well in a phase 3 clinical trial for treating pancreatic cancer. The drug daraxonrasib reduced the risk of death by nearly half, as well as shrank tumors in people who were given the drug. Pancreatic cancer has the highest mortality rate of all major cancers, and early detection is the key to treating the dis







%20top%20art%20052026%20SOURCE%20Lauf%20Cycles.jpg)



















































































































































































